|
Sysmex Corporation (6869.T) Évaluation DCF
JP | Healthcare | Medical - Instruments & Supplies | JPX
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Sysmex Corporation (6869.T) Bundle
Explorez le potentiel financier de Sysmex Corporation (6869T) avec notre calculatrice DCF conviviale! Entrez vos projections pour la croissance, les marges et les dépenses pour calculer la valeur intrinsèque de la Sysmex Corporation (6869T) et informer votre approche d'investissement.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 301,980.0 | 305,073.0 | 363,780.0 | 410,502.0 | 461,510.0 | 514,049.5 | 572,570.3 | 637,753.2 | 710,356.8 | 791,225.7 |
| Revenue Growth, % | 0 | 1.02 | 19.24 | 12.84 | 12.43 | 11.38 | 11.38 | 11.38 | 11.38 | 11.38 |
| EBITDA | 74,283.0 | 75,528.0 | 96,121.0 | 104,949.0 | 115,671.0 | 129,960.4 | 144,755.4 | 161,234.8 | 179,590.2 | 200,035.2 |
| EBITDA, % | 24.6 | 24.76 | 26.42 | 25.57 | 25.06 | 25.28 | 25.28 | 25.28 | 25.28 | 25.28 |
| Depreciation | 23,955.0 | 25,416.0 | 27,431.0 | 31,807.0 | 35,888.0 | 40,433.9 | 45,037.1 | 50,164.2 | 55,875.0 | 62,236.0 |
| Depreciation, % | 7.93 | 8.33 | 7.54 | 7.75 | 7.78 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 |
| EBIT | 50,328.0 | 50,112.0 | 68,690.0 | 73,142.0 | 79,783.0 | 89,526.5 | 99,718.4 | 111,070.6 | 123,715.2 | 137,799.2 |
| EBIT, % | 16.67 | 16.43 | 18.88 | 17.82 | 17.29 | 17.42 | 17.42 | 17.42 | 17.42 | 17.42 |
| Total Cash | 57,013.0 | 67,572.0 | 75,250.0 | 70,335.0 | 76,607.0 | 98,129.9 | 109,301.2 | 121,744.4 | 135,604.1 | 151,041.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 85,650.0 | 100,641.0 | 118,697.0 | 126,319.0 | 149,937.0 | 161,659.3 | 180,063.0 | 200,561.8 | 223,394.3 | 248,826.1 |
| Account Receivables, % | 28.36 | 32.99 | 32.63 | 30.77 | 32.49 | 31.45 | 31.45 | 31.45 | 31.45 | 31.45 |
| Inventories | 48,303.0 | 46,985.0 | 61,944.0 | 73,310.0 | 79,123.0 | 85,771.8 | 95,536.3 | 106,412.4 | 118,526.6 | 132,020.0 |
| Inventories, % | 16 | 15.4 | 17.03 | 17.86 | 17.14 | 16.69 | 16.69 | 16.69 | 16.69 | 16.69 |
| Accounts Payable | 24,245.0 | 24,347.0 | 32,111.0 | 31,678.0 | 33,602.0 | 40,953.5 | 45,615.8 | 50,808.8 | 56,593.0 | 63,035.7 |
| Accounts Payable, % | 8.03 | 7.98 | 8.83 | 7.72 | 7.28 | 7.97 | 7.97 | 7.97 | 7.97 | 7.97 |
| Capital Expenditure | -26,472.0 | -25,793.0 | -32,034.0 | -42,505.0 | -50,191.0 | -48,584.4 | -54,115.3 | -60,276.0 | -67,137.9 | -74,781.1 |
| Capital Expenditure, % | -8.77 | -8.45 | -8.81 | -10.35 | -10.88 | -9.45 | -9.45 | -9.45 | -9.45 | -9.45 |
| Tax Rate, % | 33.46 | 33.46 | 33.46 | 33.46 | 33.46 | 33.46 | 33.46 | 33.46 | 33.46 | 33.46 |
| EBITAT | 35,513.5 | 33,284.9 | 47,068.7 | 48,735.1 | 53,087.8 | 60,641.6 | 67,545.1 | 75,234.7 | 83,799.6 | 93,339.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -76,711.5 | 19,336.9 | 17,214.7 | 18,616.1 | 11,277.8 | 41,471.6 | 34,960.9 | 38,941.0 | 43,374.1 | 48,311.9 |
| WACC, % | 7.01 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 168,607.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 49,278 | |||||||||
| Terminal Value | 985,137 | |||||||||
| Present Terminal Value | 702,318 | |||||||||
| Enterprise Value | 870,925 | |||||||||
| Net Debt | -20,168 | |||||||||
| Equity Value | 891,093 | |||||||||
| Diluted Shares Outstanding, MM | 626 | |||||||||
| Equity Value Per Share | 1,422.48 |
Benefits You Will Receive
- Accurate Sysmex Financials: Access to both historical and projected data for precise valuation.
- Customizable Parameters: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Real-Time Calculations: Dynamic computation of intrinsic value and NPV.
- Scenario Testing: Evaluate various scenarios to assess Sysmex’s future performance.
- User-Friendly Interface: Designed for professionals while remaining easy to navigate for newcomers.
Key Features
- 🔍 Real-Life SYSM Financials: Pre-filled historical and projected data for Sysmex Corporation (6869T).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Sysmex’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Sysmex’s valuation instantly after making adjustments.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Operates
- Download: Access the pre-configured Excel file containing Sysmex Corporation’s (6869T) financial data.
- Customize: Modify forecasts, including expected revenue growth, EBITDA percentage, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various projections and compare results instantly.
- Make Decisions: Utilize the valuation outcomes to inform your investment approach.
Why Choose This Calculator for Sysmex Corporation (6869T)?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters effortlessly to suit your analysis.
- Real-Time Feedback: Observe immediate updates to Sysmex’s valuation as you modify inputs.
- Preloaded Financial Data: Comes equipped with Sysmex's current financial metrics for swift evaluations.
- Valuable Resource for Experts: Employed by investors and analysts for insightful decision-making.
Who Should Utilize This Tool?
- Investors: Precisely assess the fair value of Sysmex Corporation (6869T) before making investment choices.
- CFOs: Utilize a high-quality DCF model for effective financial reporting and analysis.
- Consultants: Easily customize the template for client valuation reports.
- Entrepreneurs: Gain valuable insights into financial modeling practices of leading companies.
- Educators: Employ it as a resource for teaching various valuation strategies.
Contents of the Template
- Detailed DCF Model: An editable model equipped with comprehensive valuation calculations.
- Real-World Data: Sysmex Corporation’s (6869T) historical and projected financial data preloaded for analysis.
- Customizable Variables: Modify WACC, growth rates, and tax assumptions to explore different scenarios.
- Financial Statements: Complete annual and quarterly reports for enhanced insights.
- Key Financial Ratios: Integrated analysis focusing on profitability, efficiency, and leverage.
- Interactive Dashboard: Visual outputs including charts and tables for clear and actionable insights.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.